Search results for: “biotech companies”
-
BSF and CellRev join forces to create a new Foodtech company for cultivated meat
•
LONDON: BSF, a biotech company that owns two tissue engineering companies, 3D Bio-Tissues and Kerato, has announced a…
-
AbbVie to buy ImmunoGen for $10.1 billion, boosting its oncology portfolio
•
AbbVie Inc. (NYSE: ABBV) announced today that it has agreed to acquire ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology…
-
Thermo Fisher to buy protein analysis firm Olink for $3.1 billion
•
Thermo Fisher Scientific announced on Tuesday that it would buy Olink Holding AB, a Swedish company that specializes…
-
Abpro Corporation to merge with Atlantic Coastal in $725 million deal
•
Abpro Corporation, a biotechnology company developing next-generation antibody therapies for severe and life-threatening diseases, has announced a term…
-
CROs Unveiled: 4 Things You Need to Know About Them
•
When one corporation hires another to take charge of handling its trials and extensive medical testing, the latter…
-
Ashington Innovation agrees to acquire Calon Cardio-Technology for £39 million
•
LONDON, UK: Ashington Innovation plc has entered into a non-binding heads of terms agreement with Calon Cardio-Technology Limited,…
-
Sir Nigel Rudd returns as Chairman of Destiny Pharma
•
LONDON, UK: Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of…
-
Oncimmune announces new CEO and finance director as part of leadership shake-up
•
LONDON, UK: Oncimmune Holdings plc, a company that provides autoantibody profiling services to the pharma and biotech industry,…
-
Intuitive Investments Group appoints Sir Nigel Rudd as its next chairman
•
LONDON, UK: Intuitive Investments Group plc (IIG), a closed-end investment company focused on the life sciences sector, has…
-
Nanobiotix signs deal with Janssen for cancer drug NBTXR3
•
PARIS, FRANCE: Nanobiotix, a biotechnology company developing nanotherapeutics for cancer, has announced a global deal with Janssen Pharmaceutica…
-
Frontier IP sells more Exscientia shares for $1.86 million
•
LONDON, UK: Frontier IP, a UK-based company that helps commercialise intellectual property, has announced that it has sold…
-
Dr Debra Barker appointed interim CEO of Destiny Pharma as Neil Clark steps down
•
BRIGHTON, UNITED KINGDOM: Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.